The Experts below are selected from a list of 489 Experts worldwide ranked by ideXlab platform

Gertraut Altreuther - One of the best experts on this subject based on the ideXlab platform.

  • Efficacy of Emodepside plus Toltrazuril Suspension (Procox^® Oral Suspension for Dogs) against Prepatent and Patent Infection with Isospora canis and Isospora ohioensis-Complex in Dogs
    Parasitology Research, 2011
    Co-Authors: Gertraut Altreuther, Nadine Gasda, Iris Schroeder, Anja Joachim, Terry Settje, Annette Schimmel, Douglas Hutchens, Klemens J. Krieger
    Abstract:

    Three randomised, blinded and placebo-controlled laboratory studies were conducted to evaluate the efficacy of emodepside plus toltrazuril suspension (Procox^® suspension for dogs) against Isospora canis and Isospora ohioensis -complex. Unweaned puppies were experimentally infected with sporulated oocysts of I. canis and/or I. ohioensis -complex. In each study, one group was treated during prepatency (2 or 4 days post infection) while dogs in the second group were treated individually after the onset of oocyst excretion of the respective coccidia species. The dogs were treated with the minimum therapeutic dose of 0.45 mg emodepside and 9 mg toltrazuril per kg body weight. Daily faecal oocyst counts from both groups were compared to placebotreated control groups to determine efficacy. Dogs treated during prepatent I. canis or I. ohioensis -complex infection showed significantly lower oocyst counts for up to 12 days compared to the control group. Oocyst counts were reduced by 90.2 – 100 % while the control groups continued to exhibit an adequate infection, except for one study where efficacy against prepatent I. canis infection faded 13 days after treatment. Following treatment of patent I. canis or I. ohioensis -complex infections, significantly lowered oocyst counts were observed for up to 9 days compared to the control group. Faecal oocyst counts were reduced by 91.5 – 100 %. In all three studies the number of days with diarrhoea was significantly lower when dogs were treated during prepatent Isospora spp. infection compared to the control groups. No adverse drug reactions were observed during the studies. In conclusion, the studies demonstrated that emodepside plus toltrazuril suspension is an efficient coccidiocide for dogs.

  • efficacy of emodepside plus toltrazuril suspension procox oral suspension for dogs against prepatent and patent infection with Isospora canis and Isospora ohioensis complex in dogs
    Parasitology Research, 2011
    Co-Authors: Gertraut Altreuther, Nadine Gasda, Iris Schroeder, Anja Joachim, Terry Settje, Annette Schimmel, Douglas Hutchens, Klemens Krieger
    Abstract:

    Three randomised, blinded and placebo-controlled laboratory studies were conducted to evaluate the efficacy of emodepside plus toltrazuril suspension (Procox® suspension for dogs) against Isospora canis and Isospora ohioensis-complex. Unweaned puppies were experimentally infected with sporulated oocysts of I. canis and/or I. ohioensis-complex. In each study, one group was treated during prepatency (2 or 4 days post infection) while dogs in the second group were treated individually after the onset of oocyst excretion of the respective coccidia species. The dogs were treated with the minimum therapeutic dose of 0.45 mg emodepside and 9 mg toltrazuril per kg body weight. Daily faecal oocyst counts from both groups were compared to placebotreated control groups to determine efficacy.

  • Efficacy of Emodepside plus Toltrazuril Suspension (Procox ® Oral Suspension for Dogs) against Prepatent and Patent Infection with Isospora canis and Isospora ohioensis -Complex in Dogs
    Parasitology Research, 2011
    Co-Authors: Gertraut Altreuther, Nadine Gasda, Iris Schroeder, Anja Joachim, Terry Settje, Annette Schimmel, Douglas Hutchens, Klemens Krieger
    Abstract:

    Three randomised, blinded and placebo-controlled laboratory studies were conducted to evaluate the efficacy of emodepside plus toltrazuril suspension (Procox® suspension for dogs) against Isospora canis and Isospora ohioensis-complex. Unweaned puppies were experimentally infected with sporulated oocysts of I. canis and/or I. ohioensis-complex. In each study, one group was treated during prepatency (2 or 4 days post infection) while dogs in the second group were treated individually after the onset of oocyst excretion of the respective coccidia species. The dogs were treated with the minimum therapeutic dose of 0.45 mg emodepside and 9 mg toltrazuril per kg body weight. Daily faecal oocyst counts from both groups were compared to placebotreated control groups to determine efficacy.

  • Efficacy of emodepside plus toltrazuril suspension (Procox(®) oral suspension for dogs) against prepatent and patent infection with Isospora canis and Isospora ohioensis-complex in dogs.
    Parasitology research, 2011
    Co-Authors: Gertraut Altreuther, Nadine Gasda, Iris Schroeder, Anja Joachim, Terry Settje, Annette Schimmel, Douglas Hutchens, Klemens J. Krieger
    Abstract:

    Three randomised, blinded and placebo-controlled laboratory studies were conducted to evaluate the efficacy of emodepside plus toltrazuril suspension (Procox(®) suspension for dogs) against Isospora canis and Isospora ohioensis-complex. Unweaned puppies were experimentally infected with sporulated oocysts of I. canis and/or I. ohioensis-complex. In each study, one group was treated during prepatency (2 or 4 days post infection) while dogs in the second group were treated individually after the onset of oocyst excretion of the respective coccidia species. The dogs were treated with the minimum therapeutic dose of 0.45 mg emodepside and 9 mg toltrazuril per kg body weight. Daily faecal oocyst counts from both groups were compared to placebotreated control groups to determine efficacy.Dogs treated during prepatent I. canis or I. ohioensis-complex infection showed significantly lower oocyst counts for up to 12 days compared to the control group. Oocyst counts were reduced by 90.2 - 100 % while the control groups continued to exhibit an adequate infection, except for one study where efficacy against prepatent I. canis infection faded 13 days after treatment. Following treatment of patent I. canis or I. ohioensis-complex infections, significantly lowered oocyst counts were observed for up to 9 days compared to the control group. Faecal oocyst counts were reduced by 91.5 - 100 %. In all three studies the number of days with diarrhoea was significantly lower when dogs were treated during prepatent Isospora spp. infection compared to the control groups. No adverse drug reactions were observed during the studies. In conclusion, the studies demonstrated that emodepside plus toltrazuril suspension is an efficient coccidiocide for dogs.

Klemens Krieger - One of the best experts on this subject based on the ideXlab platform.

Klemens J. Krieger - One of the best experts on this subject based on the ideXlab platform.

  • Efficacy of Emodepside plus Toltrazuril Suspension (Procox^® Oral Suspension for Dogs) against Prepatent and Patent Infection with Isospora canis and Isospora ohioensis-Complex in Dogs
    Parasitology Research, 2011
    Co-Authors: Gertraut Altreuther, Nadine Gasda, Iris Schroeder, Anja Joachim, Terry Settje, Annette Schimmel, Douglas Hutchens, Klemens J. Krieger
    Abstract:

    Three randomised, blinded and placebo-controlled laboratory studies were conducted to evaluate the efficacy of emodepside plus toltrazuril suspension (Procox^® suspension for dogs) against Isospora canis and Isospora ohioensis -complex. Unweaned puppies were experimentally infected with sporulated oocysts of I. canis and/or I. ohioensis -complex. In each study, one group was treated during prepatency (2 or 4 days post infection) while dogs in the second group were treated individually after the onset of oocyst excretion of the respective coccidia species. The dogs were treated with the minimum therapeutic dose of 0.45 mg emodepside and 9 mg toltrazuril per kg body weight. Daily faecal oocyst counts from both groups were compared to placebotreated control groups to determine efficacy. Dogs treated during prepatent I. canis or I. ohioensis -complex infection showed significantly lower oocyst counts for up to 12 days compared to the control group. Oocyst counts were reduced by 90.2 – 100 % while the control groups continued to exhibit an adequate infection, except for one study where efficacy against prepatent I. canis infection faded 13 days after treatment. Following treatment of patent I. canis or I. ohioensis -complex infections, significantly lowered oocyst counts were observed for up to 9 days compared to the control group. Faecal oocyst counts were reduced by 91.5 – 100 %. In all three studies the number of days with diarrhoea was significantly lower when dogs were treated during prepatent Isospora spp. infection compared to the control groups. No adverse drug reactions were observed during the studies. In conclusion, the studies demonstrated that emodepside plus toltrazuril suspension is an efficient coccidiocide for dogs.

  • Efficacy of emodepside plus toltrazuril suspension (Procox(®) oral suspension for dogs) against prepatent and patent infection with Isospora canis and Isospora ohioensis-complex in dogs.
    Parasitology research, 2011
    Co-Authors: Gertraut Altreuther, Nadine Gasda, Iris Schroeder, Anja Joachim, Terry Settje, Annette Schimmel, Douglas Hutchens, Klemens J. Krieger
    Abstract:

    Three randomised, blinded and placebo-controlled laboratory studies were conducted to evaluate the efficacy of emodepside plus toltrazuril suspension (Procox(®) suspension for dogs) against Isospora canis and Isospora ohioensis-complex. Unweaned puppies were experimentally infected with sporulated oocysts of I. canis and/or I. ohioensis-complex. In each study, one group was treated during prepatency (2 or 4 days post infection) while dogs in the second group were treated individually after the onset of oocyst excretion of the respective coccidia species. The dogs were treated with the minimum therapeutic dose of 0.45 mg emodepside and 9 mg toltrazuril per kg body weight. Daily faecal oocyst counts from both groups were compared to placebotreated control groups to determine efficacy.Dogs treated during prepatent I. canis or I. ohioensis-complex infection showed significantly lower oocyst counts for up to 12 days compared to the control group. Oocyst counts were reduced by 90.2 - 100 % while the control groups continued to exhibit an adequate infection, except for one study where efficacy against prepatent I. canis infection faded 13 days after treatment. Following treatment of patent I. canis or I. ohioensis-complex infections, significantly lowered oocyst counts were observed for up to 9 days compared to the control group. Faecal oocyst counts were reduced by 91.5 - 100 %. In all three studies the number of days with diarrhoea was significantly lower when dogs were treated during prepatent Isospora spp. infection compared to the control groups. No adverse drug reactions were observed during the studies. In conclusion, the studies demonstrated that emodepside plus toltrazuril suspension is an efficient coccidiocide for dogs.

Douglas Hutchens - One of the best experts on this subject based on the ideXlab platform.

  • Efficacy of Emodepside plus Toltrazuril Suspension (Procox^® Oral Suspension for Dogs) against Prepatent and Patent Infection with Isospora canis and Isospora ohioensis-Complex in Dogs
    Parasitology Research, 2011
    Co-Authors: Gertraut Altreuther, Nadine Gasda, Iris Schroeder, Anja Joachim, Terry Settje, Annette Schimmel, Douglas Hutchens, Klemens J. Krieger
    Abstract:

    Three randomised, blinded and placebo-controlled laboratory studies were conducted to evaluate the efficacy of emodepside plus toltrazuril suspension (Procox^® suspension for dogs) against Isospora canis and Isospora ohioensis -complex. Unweaned puppies were experimentally infected with sporulated oocysts of I. canis and/or I. ohioensis -complex. In each study, one group was treated during prepatency (2 or 4 days post infection) while dogs in the second group were treated individually after the onset of oocyst excretion of the respective coccidia species. The dogs were treated with the minimum therapeutic dose of 0.45 mg emodepside and 9 mg toltrazuril per kg body weight. Daily faecal oocyst counts from both groups were compared to placebotreated control groups to determine efficacy. Dogs treated during prepatent I. canis or I. ohioensis -complex infection showed significantly lower oocyst counts for up to 12 days compared to the control group. Oocyst counts were reduced by 90.2 – 100 % while the control groups continued to exhibit an adequate infection, except for one study where efficacy against prepatent I. canis infection faded 13 days after treatment. Following treatment of patent I. canis or I. ohioensis -complex infections, significantly lowered oocyst counts were observed for up to 9 days compared to the control group. Faecal oocyst counts were reduced by 91.5 – 100 %. In all three studies the number of days with diarrhoea was significantly lower when dogs were treated during prepatent Isospora spp. infection compared to the control groups. No adverse drug reactions were observed during the studies. In conclusion, the studies demonstrated that emodepside plus toltrazuril suspension is an efficient coccidiocide for dogs.

  • efficacy of emodepside plus toltrazuril suspension procox oral suspension for dogs against prepatent and patent infection with Isospora canis and Isospora ohioensis complex in dogs
    Parasitology Research, 2011
    Co-Authors: Gertraut Altreuther, Nadine Gasda, Iris Schroeder, Anja Joachim, Terry Settje, Annette Schimmel, Douglas Hutchens, Klemens Krieger
    Abstract:

    Three randomised, blinded and placebo-controlled laboratory studies were conducted to evaluate the efficacy of emodepside plus toltrazuril suspension (Procox® suspension for dogs) against Isospora canis and Isospora ohioensis-complex. Unweaned puppies were experimentally infected with sporulated oocysts of I. canis and/or I. ohioensis-complex. In each study, one group was treated during prepatency (2 or 4 days post infection) while dogs in the second group were treated individually after the onset of oocyst excretion of the respective coccidia species. The dogs were treated with the minimum therapeutic dose of 0.45 mg emodepside and 9 mg toltrazuril per kg body weight. Daily faecal oocyst counts from both groups were compared to placebotreated control groups to determine efficacy.

  • Efficacy of Emodepside plus Toltrazuril Suspension (Procox ® Oral Suspension for Dogs) against Prepatent and Patent Infection with Isospora canis and Isospora ohioensis -Complex in Dogs
    Parasitology Research, 2011
    Co-Authors: Gertraut Altreuther, Nadine Gasda, Iris Schroeder, Anja Joachim, Terry Settje, Annette Schimmel, Douglas Hutchens, Klemens Krieger
    Abstract:

    Three randomised, blinded and placebo-controlled laboratory studies were conducted to evaluate the efficacy of emodepside plus toltrazuril suspension (Procox® suspension for dogs) against Isospora canis and Isospora ohioensis-complex. Unweaned puppies were experimentally infected with sporulated oocysts of I. canis and/or I. ohioensis-complex. In each study, one group was treated during prepatency (2 or 4 days post infection) while dogs in the second group were treated individually after the onset of oocyst excretion of the respective coccidia species. The dogs were treated with the minimum therapeutic dose of 0.45 mg emodepside and 9 mg toltrazuril per kg body weight. Daily faecal oocyst counts from both groups were compared to placebotreated control groups to determine efficacy.

  • Efficacy of emodepside plus toltrazuril suspension (Procox(®) oral suspension for dogs) against prepatent and patent infection with Isospora canis and Isospora ohioensis-complex in dogs.
    Parasitology research, 2011
    Co-Authors: Gertraut Altreuther, Nadine Gasda, Iris Schroeder, Anja Joachim, Terry Settje, Annette Schimmel, Douglas Hutchens, Klemens J. Krieger
    Abstract:

    Three randomised, blinded and placebo-controlled laboratory studies were conducted to evaluate the efficacy of emodepside plus toltrazuril suspension (Procox(®) suspension for dogs) against Isospora canis and Isospora ohioensis-complex. Unweaned puppies were experimentally infected with sporulated oocysts of I. canis and/or I. ohioensis-complex. In each study, one group was treated during prepatency (2 or 4 days post infection) while dogs in the second group were treated individually after the onset of oocyst excretion of the respective coccidia species. The dogs were treated with the minimum therapeutic dose of 0.45 mg emodepside and 9 mg toltrazuril per kg body weight. Daily faecal oocyst counts from both groups were compared to placebotreated control groups to determine efficacy.Dogs treated during prepatent I. canis or I. ohioensis-complex infection showed significantly lower oocyst counts for up to 12 days compared to the control group. Oocyst counts were reduced by 90.2 - 100 % while the control groups continued to exhibit an adequate infection, except for one study where efficacy against prepatent I. canis infection faded 13 days after treatment. Following treatment of patent I. canis or I. ohioensis-complex infections, significantly lowered oocyst counts were observed for up to 9 days compared to the control group. Faecal oocyst counts were reduced by 91.5 - 100 %. In all three studies the number of days with diarrhoea was significantly lower when dogs were treated during prepatent Isospora spp. infection compared to the control groups. No adverse drug reactions were observed during the studies. In conclusion, the studies demonstrated that emodepside plus toltrazuril suspension is an efficient coccidiocide for dogs.

Annette Schimmel - One of the best experts on this subject based on the ideXlab platform.

  • Efficacy of Emodepside plus Toltrazuril Suspension (Procox^® Oral Suspension for Dogs) against Prepatent and Patent Infection with Isospora canis and Isospora ohioensis-Complex in Dogs
    Parasitology Research, 2011
    Co-Authors: Gertraut Altreuther, Nadine Gasda, Iris Schroeder, Anja Joachim, Terry Settje, Annette Schimmel, Douglas Hutchens, Klemens J. Krieger
    Abstract:

    Three randomised, blinded and placebo-controlled laboratory studies were conducted to evaluate the efficacy of emodepside plus toltrazuril suspension (Procox^® suspension for dogs) against Isospora canis and Isospora ohioensis -complex. Unweaned puppies were experimentally infected with sporulated oocysts of I. canis and/or I. ohioensis -complex. In each study, one group was treated during prepatency (2 or 4 days post infection) while dogs in the second group were treated individually after the onset of oocyst excretion of the respective coccidia species. The dogs were treated with the minimum therapeutic dose of 0.45 mg emodepside and 9 mg toltrazuril per kg body weight. Daily faecal oocyst counts from both groups were compared to placebotreated control groups to determine efficacy. Dogs treated during prepatent I. canis or I. ohioensis -complex infection showed significantly lower oocyst counts for up to 12 days compared to the control group. Oocyst counts were reduced by 90.2 – 100 % while the control groups continued to exhibit an adequate infection, except for one study where efficacy against prepatent I. canis infection faded 13 days after treatment. Following treatment of patent I. canis or I. ohioensis -complex infections, significantly lowered oocyst counts were observed for up to 9 days compared to the control group. Faecal oocyst counts were reduced by 91.5 – 100 %. In all three studies the number of days with diarrhoea was significantly lower when dogs were treated during prepatent Isospora spp. infection compared to the control groups. No adverse drug reactions were observed during the studies. In conclusion, the studies demonstrated that emodepside plus toltrazuril suspension is an efficient coccidiocide for dogs.

  • efficacy of emodepside plus toltrazuril suspension procox oral suspension for dogs against prepatent and patent infection with Isospora canis and Isospora ohioensis complex in dogs
    Parasitology Research, 2011
    Co-Authors: Gertraut Altreuther, Nadine Gasda, Iris Schroeder, Anja Joachim, Terry Settje, Annette Schimmel, Douglas Hutchens, Klemens Krieger
    Abstract:

    Three randomised, blinded and placebo-controlled laboratory studies were conducted to evaluate the efficacy of emodepside plus toltrazuril suspension (Procox® suspension for dogs) against Isospora canis and Isospora ohioensis-complex. Unweaned puppies were experimentally infected with sporulated oocysts of I. canis and/or I. ohioensis-complex. In each study, one group was treated during prepatency (2 or 4 days post infection) while dogs in the second group were treated individually after the onset of oocyst excretion of the respective coccidia species. The dogs were treated with the minimum therapeutic dose of 0.45 mg emodepside and 9 mg toltrazuril per kg body weight. Daily faecal oocyst counts from both groups were compared to placebotreated control groups to determine efficacy.

  • Efficacy of Emodepside plus Toltrazuril Suspension (Procox ® Oral Suspension for Dogs) against Prepatent and Patent Infection with Isospora canis and Isospora ohioensis -Complex in Dogs
    Parasitology Research, 2011
    Co-Authors: Gertraut Altreuther, Nadine Gasda, Iris Schroeder, Anja Joachim, Terry Settje, Annette Schimmel, Douglas Hutchens, Klemens Krieger
    Abstract:

    Three randomised, blinded and placebo-controlled laboratory studies were conducted to evaluate the efficacy of emodepside plus toltrazuril suspension (Procox® suspension for dogs) against Isospora canis and Isospora ohioensis-complex. Unweaned puppies were experimentally infected with sporulated oocysts of I. canis and/or I. ohioensis-complex. In each study, one group was treated during prepatency (2 or 4 days post infection) while dogs in the second group were treated individually after the onset of oocyst excretion of the respective coccidia species. The dogs were treated with the minimum therapeutic dose of 0.45 mg emodepside and 9 mg toltrazuril per kg body weight. Daily faecal oocyst counts from both groups were compared to placebotreated control groups to determine efficacy.

  • Efficacy of emodepside plus toltrazuril suspension (Procox(®) oral suspension for dogs) against prepatent and patent infection with Isospora canis and Isospora ohioensis-complex in dogs.
    Parasitology research, 2011
    Co-Authors: Gertraut Altreuther, Nadine Gasda, Iris Schroeder, Anja Joachim, Terry Settje, Annette Schimmel, Douglas Hutchens, Klemens J. Krieger
    Abstract:

    Three randomised, blinded and placebo-controlled laboratory studies were conducted to evaluate the efficacy of emodepside plus toltrazuril suspension (Procox(®) suspension for dogs) against Isospora canis and Isospora ohioensis-complex. Unweaned puppies were experimentally infected with sporulated oocysts of I. canis and/or I. ohioensis-complex. In each study, one group was treated during prepatency (2 or 4 days post infection) while dogs in the second group were treated individually after the onset of oocyst excretion of the respective coccidia species. The dogs were treated with the minimum therapeutic dose of 0.45 mg emodepside and 9 mg toltrazuril per kg body weight. Daily faecal oocyst counts from both groups were compared to placebotreated control groups to determine efficacy.Dogs treated during prepatent I. canis or I. ohioensis-complex infection showed significantly lower oocyst counts for up to 12 days compared to the control group. Oocyst counts were reduced by 90.2 - 100 % while the control groups continued to exhibit an adequate infection, except for one study where efficacy against prepatent I. canis infection faded 13 days after treatment. Following treatment of patent I. canis or I. ohioensis-complex infections, significantly lowered oocyst counts were observed for up to 9 days compared to the control group. Faecal oocyst counts were reduced by 91.5 - 100 %. In all three studies the number of days with diarrhoea was significantly lower when dogs were treated during prepatent Isospora spp. infection compared to the control groups. No adverse drug reactions were observed during the studies. In conclusion, the studies demonstrated that emodepside plus toltrazuril suspension is an efficient coccidiocide for dogs.